Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Antibody test negative; This literature marketed report has been received from the authors of a published literature article, and refers to a 33-year-old male patient The patient's medical history included 2 episodes of immune thrombocytopenia (ITP). The patient's concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient started therapy with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), Solution for injection (indication, expiration date, and lot # were not reported). On an unknown date, the patient experienced Antibody test negative. Immunoglobulin (Ig) gG was 249 mg/dL, IgA was 22 mg/dL, IgM was 25 mg/dL. The was referred to immunology and was found to have a poor pneumococcal vaccine response (only 4 of 23 serotypes became positive). At the reporting time, the outcome of Antibody test negative was unknown. The authors considered the event of Antibody test negative to be related to Pneumococcal Vaccine, Polyvalent (23-valent).
Medical History/Concurrent Conditions: Immune thrombocytopenia
Test Name: IgG; Test Result: 249 mg/dl; Result Unstructured Data: 249 mg/dL; Test Name: IgA; Test Result: 22 mg/dl; Result Unstructured Data: 22 mg/dL; Test Name: IgM; Result Unstructured Data: less than 25 mg/dL